Belgium· BE-AMP-SAM537324-00
Bortezomib Krka 1 mg
A bortezomib product containing bortezomib mannitol boronic ester, registered in Belgium by KRKA d.d. Novo mesto. The same ATC class is registered in 3 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Bortezomib is registered in 3 of 19 countries.
Countries holding a registration under ATC L01XX32 (bortezomib), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 2 of them publish a price we can compare per daily dose
Bortezomib · ATC L01XX32
3 / 19 countries
- Belgiumprice
- Ireland
- Polandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Bortezomib Mannitol Boronic Ester
- Manufacturer
- KRKA d.d. Novo mesto
- Country
- Belgium (BE)
- ATC code
- L01XX32
- ATC class
- Bortezomib
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb7732118
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
587 interactions on record for bortezomib.
Graded by severity as the source publishes them — 45 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bortezomib · interactions on record
587 records
- 45 severe
- 250 moderate
- 66 minor
- 226 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- RifampicinJ04AB02severe
- RifabutinJ04AB04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bortezomib in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c230a5b2-5446-4e52-9773-e9f6c26b2a51 GET /v1/drugs/c230a5b2-5446-4e52-9773-e9f6c26b2a51?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for solution for injection",
"source": "afmps",
"status": "REVOKED",
"name_en": "Bortezomib Krka 1 mg",
"name_fr": "Bortezomib Krka 1 mg",
"name_nl": "Bortezomib Krka 1 mg",
"amp_code": "SAM537324-00",
"strengths": [
"1.0000",
"1.0000",
"10.0000"
],
"pack_count": 3,
"substances": [
"Bortezomib Mannitol Boronic Ester",
"Bortezomib",
"Mannitol"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Bortezomib",
"authorisation_numbers": [
"BE537324"
]
}See everything about bortezomib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.